Facility
Kaplife produces more than 240 million units of Respules and SWFI products. We also contribute to the eye, ear, and nasal care industry with highly optimized solutions that produce over 300 million units every year. Our capacity stems from a dedicated production line for each product category.
We employ Aseptic Form-Fill-Seal (AFFS) to form containers, fill them with formulations and produce hermetically sealed products. The entire production process takes place in designated clean rooms minimizing direct human intervention, eliminating contamination risks and maximizing quality. Kaplife is a secure source of delivery of pharmaceutical manufacturing in many countries.
We specialize in producing safe to use parenteral drugs that increase client goodwill and benefit consumers without harmful side-effects. Over the years we have gained immense expertise in producing large-volume parenteral (LVP) and small-volume parenteral (SVP) products.
Producing high-quality products with low-quality packaging is counterproductive. Hence we employ Aseptic Form-Fill-Seal (AFFS) manufacturing with continuous quality checks ensure that our products reach consumers with the utmost safety and integrity.
Every Respule we produce is crafted with care using 100% recyclable, eco-friendly (C2H4)n polyethylene granules sourced from Norway, Northern Europe. The entire production plant functions on Aseptic Form-Fill-Seal (AFFS) technology guaranteeing zero human-intervention and assuring minuscule contamination risk.